Shinpoong Pharmaceutical Co Ltd is a Korea-based company primarily engaged in the manufacture and sale of pharmaceutical products. The Company is mainly engaged in the manufacture and sale of joint function improvement agents, adhesion prevention agents, combination drugs for hypertension, combination drugs for hyperlipidemia, wound dressings, and non-steroidal anti-inflammatory analgesics. The Company mainly sells its products in domestic and overseas markets.

Employees

809

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
23/09/26	₩13,850.00	-0.43%	2,270
22/09/26	₩13,910.00	+0.07%	2,173
21/09/26	₩13,900.00	+0.72%	2,317
18/09/26	₩13,800.00	-2.68%	2,489
17/09/26	₩14,180.00	+1.43%	810

End-of-day quote Korea S.E.

More quotes

End-of-day quote Korea S.E. 23/09/2026			5-day change	1st Jan Change
13,850.00 ^KRW	-0.43%		+0.36%	-41.06%

12-03	Shinpoong Pharmaceutical Co.,Ltd announced that it has received KRW 11.5 billion in funding	CI
11-25	Shinpoong Pharmaceutical to divest 11.5 billion won worth of own shares	RE

Market Cap	478B 352M 309M 292M 266M 498M 33.76B 501M 3.49B 1.35B 17.25B 1.32B 1.29B 55.42B	P/E 2024	-35.7x	P/E 2025	81.8x
Enterprise Value	462B 341M 299M 282M 257M 482M 32.65B 485M 3.38B 1.31B 16.68B 1.28B 1.25B 53.61B	EV / Sales 2024	2.43x	EV / Sales 2025	3.08x
Free-Float	58.7%	Yield 2024 *	-	Yield 2025	-

12-03	Shinpoong Pharmaceutical Co.,Ltd announced that it has received KRW 11.5 billion in funding	CI
11-25	Shinpoong Pharmaceutical to divest 11.5 billion won worth of own shares	RE
11-25	Shinpoong Pharmaceutical Co.,Ltd announced that it expects to receive KRW 11.5 billion in funding	CI
11-20	Shinpoong Pharmaceutical to invest 62.4 billion won in facilities	RE
13/06/24	Shinpoong Pharmaceutical Co.,Ltd(KOSE:A019170) dropped from KOSPI 200 Index	CI
24/04/24	Korean Sugar Imports Plunge 14% as Diabetes Cases Surge	MT
25/09/23	South Korean Shares Continue Losing Streak Amid High Interest Rate Woes	MT
25/09/23	Financial Regulator Probes Shinpoong Pharmaceutical Employees for Trading Using Undisclosed Information	MT
18/09/23	Shin Poong Pharm.Co.,Ltd.(KOSE:A019170) dropped from FTSE All-World Index	CI
15/05/23	Shin Poong Pharm.Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
11/02/22	MSCI Korea Index Adds Meritz Financial, Meritz Fire & Marine Insurance	MT
22/03/21	Shin Poong Pharm.Co.,Ltd.(KOSE:A019170) added to FTSE All-World Index	CI
31/12/20	Shin Poong Pharm : A (markets) journal of the plague year	RE

25/11/22	Strong Recommendation for Pyronaridine-Artesunate in Revised World Health Organization (WHO) Malaria Treatment Guidelines	AQ
25/11/22	Strong Recommendation for Pyronaridine-Artesunate in Revised World Health Organization (WHO) Malaria Treatment Guidelines Inclusion in the latest version of the WHO Guidelines for malaria is a key step towards broader use of the medicine	AQ

Shinpoong Pharmaceutical Co.,Ltd Stock Korea S.E.

Stocks

A019175

KR7019171008

Pharmaceuticals

Valuation: Shinpoong Pharmaceutical Co.,Ltd

Chart: Shinpoong Pharmaceutical Co.,Ltd

Latest news: Shinpoong Pharmaceutical Co.,Ltd

Press Releases: Shinpoong Pharmaceutical Co.,Ltd

News in other languages: Shinpoong Pharmaceutical Co.,Ltd

Quotes and Performance

Price Extremes

Managers and Directors: Shinpoong Pharmaceutical Co.,Ltd

Generic Pharmaceuticals

Financials

Company Profile

Quotes

1 day	-0.43%
1 week	+0.36%
Current month	-6.92%
1 month	+1.32%
3 months	+1.84%
6 months	-19.05%
Current year	-41.06%

1 week	13,760	14,300
1 month	13,000	17,400
Current year	7,570	26,650
1 year	7,570	28,500
3 years	7,570	55,000
5 years	7,570	135,000
10 years	3,800	280,000

Manager	Title	Age	Since
Je-Man Yoo CEO	Chief Executive Officer	69	21/03/2014
Ju-Yeong Seong PRN	Corporate Officer/Principal	61	31/03/2023
Chung Joo PRN	Corporate Officer/Principal	53	-

Director	Title	Age	Since
Je-Man Yoo BRD	Director/Board Member	69	21/03/2014
Jin-Young Jeong BRD	Director/Board Member	67	29/03/2019
Chan-Ho Lee BRD	Director/Board Member	54	27/03/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SHINPOONG PHARMACEUTICAL CO.,LTD	-0.43%	+0.36%	-	-	352M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.12%	+0.81%	+13.81%	+64.78%	46.37B
OTSUKA HOLDINGS CO., LTD.	+1.09%	+0.36%	+39.50%	+107.67%	37.26B
ZYDUS LIFESCIENCES LIMITED	+2.00%	+3.78%	+18.12%	+99.54%	12.53B
CIPLA LIMITED	+0.05%	+0.37%	-7.29%	+18.68%	11.8B
KRKA, D. D.	0.00%	0.00%	+18.72%	+139.63%	8.97B
GEDEON RICHTER	-1.34%	-2.73%	+27.67%	+37.52%	7.09B
GLENMARK PHARMACEUTICALS LIMITED	-2.07%	-2.75%	+17.20%	+202.97%	7.01B
ONO PHARMACEUTICAL CO., LTD.	+1.43%	+2.22%	+43.10%	-14.21%	7.29B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-2.45%	-0.59%	-51.49%	+4.53%	4.99B
Average	-0.16%	+0.30%	+13.26%	+73.46%	15.92B
Weighted average by Cap.	+0.32%	-0.28%	+19.51%	+79.15%

	2024	2025
Net sales	221B 163M 143M 135M 123M 230M 15.61B 232M 1.62B 626M 7.98B 612M 598M 25.63B	235B 173M 152M 143M 131M 244M 16.57B 246M 1.71B 664M 8.47B 649M 635M 27.21B
Net income	-15.39B -11.34M -9.95M -9.39M -8.56M -16.03M -1.09B -16.14M -112M -43.54M -555M -42.56M -41.64M -1.78B	8.83B 6.5M 5.7M 5.39M 4.91M 9.19M 623M 9.26M 64.48M 24.97M 318M 24.41M 23.88M 1.02B
Net Debt	-1.86B -1.37M -1.2M -1.14M -1.04M -1.94M -132M -1.96M -13.62M -5.27M -67.23M -5.16M -5.04M -216M	-15.65B -11.53M -10.12M -9.55M -8.71M -16.3M -1.11B -16.42M -114M -44.29M -565M -43.29M -42.35M -1.81B